Radiation absorbed dose estimates for indium-111-labeled B72.3, an IgG antibody to ovarian and colorectal cancer: MIRD dose estimate report No. 18.
Mardirossian
G
G
Department of Nuclear Medicine, University of Massachusetts Medical Center, Worcester 01655, USA.
Brill
A B
AB
Harwood
S J
SJ
Olsen
J
J
Dwyer
K A
KA
Siegel
J A
JA
D000911:Antibodies, Monoclonal / Q000493:pharmacokinetics; D015179:Colorectal Neoplasms / Q000532:radiotherapy*; D005260:Female; D006801:Humans; D007205:Indium Radioisotopes / Q000493:pharmacokinetics; D008297:Male; D009842:Oligopeptides / Q000493:pharmacokinetics; D010051:Ovarian Neoplasms / Q000532:radiotherapy*; D004369:Pentetic Acid / Q000031:analogs & derivatives* / Q000493:pharmacokinetics; D016499:Radioimmunotherapy; D011879:Radiotherapy Dosage; D014018:Tissue Distribution
D000911:Antibodies, Monoclonal; C063430:Indium 111In-satumomab pendetide; D007205:Indium Radioisotopes; D009842:Oligopeptides; D004369:Pentetic Acid